Confidential 发表于 2025-3-23 11:11:23

http://reply.papertrans.cn/3/223/22213/22213-11.png

最有利 发表于 2025-3-23 14:39:31

Submitted on: 07 May 2019.
Revised on: 21 May 2019.
Accepted on: 31 May 2019.
MOLECULAR CANCER RESEARCH

Hiatus 发表于 2025-3-23 19:57:14

http://reply.papertrans.cn/3/223/22213/22213-13.png

transdermal 发表于 2025-3-23 22:35:19

Submitted on: 29 April 2005.
Revised on: 04 June 2005.
Accepted on: 15 June 2005.
MOLECULAR CANCER RESEARCH---AMER ASSOC CANCER RESEARCH

大洪水 发表于 2025-3-24 05:01:59

http://reply.papertrans.cn/3/223/22213/22213-15.png

Endemic 发表于 2025-3-24 09:43:30

http://reply.papertrans.cn/3/223/22213/22213-16.png

低能儿 发表于 2025-3-24 14:39:52

http://reply.papertrans.cn/3/223/22213/22213-17.png

Consequence 发表于 2025-3-24 17:39:13

Submitted on: 17 August 1998.
Revised on: 26 September 1998.
Accepted on: 08 October 1998.
MOLECULAR CANCER RESEARCH

伦理学 发表于 2025-3-24 22:28:43

http://reply.papertrans.cn/3/223/22213/22213-19.png

Enteropathic 发表于 2025-3-25 02:28:47

http://reply.papertrans.cn/3/223/22213/22213-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊MOLECULAR CANCER RESEARCH 2024/2025影响因子:4.167 (MOL CANCER RES) (1541-7786). (CELL BIOLOGY)(细胞生物学)Science Citation